Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyoma × Oxytocin × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sexual Infantilism 1 Polycystic Ovary Syndrome 1 Neoplasm Metastasis 1 Myoma 1 Leiomyoma 1 Hemorrhage 1 Diabetes Insipidus 1 Craniopharyngioma 1 Blood Loss, Surgical 1

Interventions

ulipristal acetate 11 Uterine Myomectomy 8 Uterine Artery Embolization 7 Tranexamic Acid 6 Bupivacaine 6 Mifepristone 5 Leuprolide 5 Saline Solution 4 Letrozole 4 Hysterectomy 4 epigallocatechin gallate 3 Sodium Chloride 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 ulipristal 2 cetrorelix 2 Vitamin B 6 2 Tea 2 Tablets 2 Surveys and Questionnaires 2 Radiofrequency Ablation 2 Observation 2 Lidocaine 2 Hysteroscopy 2 Goserelin 2 Gonadotropins 2 Chorionic Gonadotropin 2 Anesthesia, General 2 tibolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04996498 2023-11-07

oxytocin

Ain Shams Maternity Hospital

Phase NA Completed

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡